Using multiple logistic regression analysis, all clinicopathological parameters, including tumor size, lymph node status, ER and PR status, HER2 expression, and molecular subtype, failed to predict the expression of ANGPTL4. The gene discussed is ANGPTL4; the disease is neoplasm.